Potency of Δ9-THC and other cannabinoids in cannabis in England in 2005:: Implications for psychoactivity and pharmacology

被引:169
作者
Potter, David J. [1 ]
Clark, Peter [2 ]
Brown, Marc B. [3 ]
机构
[1] Kings Coll London, Dept Pharm, London SE1 9NH, England
[2] GW Pharmaceut Ltd, Salisbury SP4 0JQ, Wilts, England
[3] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England
关键词
forensic science; herbal cannabis; marijuana; sinsemilla; resin; hashish; skunk; potency; cannabinoid; Delta; 9-tetrahydrocannabinol; cannabidiol; cannabinol;
D O I
10.1111/j.1556-4029.2007.00603.x
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Gas chromatography was used to study the cannabinoid content ("potency") of illicit cannabis seized by police in England in 2004/5. Of the four hundred and fifty two samples, indoor-grown unpollinated female cannabis ("sinsemilla") was the most frequent form, followed by resin (hashish) and imported outdoor-grown herbal cannabis (marijuana). The content of the psychoactive cannabinoid Delta(9)-tetrahydrocannabinol (THC) varied widely. The median THC content of herbal cannabis and resin was 2.1% and 3.5%, respectively. The median 13.9% THC content of sinsemilla was significantly higher than that recorded in the UK in 1996/8. In sinsemilla and imported herbal cannabis, the content of the antipsychotic cannabinoid cannabidiol (CBD) was extremely low. In resin, however, the average CBD content exceeded that of THC, and the relative proportions of the two cannabinoids varied widely between samples. The increases in average THC content and relative popularity of sinsemilla cannabis, combined with the absence of the anti-psychotic cannabinoid CBD, suggest that the current trends in cannabis use pose an increasing risk to those users susceptible to the harmful psychological effects associated with high doses of THC.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 28 条
[1]  
[Anonymous], 2004, MED USES CANNABIS CA
[2]  
[Anonymous], 2002, J PALLIAT CARE
[3]  
[Anonymous], 2006 WORLD DRUG REP
[4]   Causal association between cannabis and psychosis: examination of the evidence [J].
Arseneault, L ;
Cannon, M ;
Witton, J ;
Murray, RM .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :110-117
[5]  
BARBER A, 1996, HOME OFFICE STAT B, V25
[6]  
British Medical Association, 1997, THER US CANN
[7]  
Clark R. A., 2001, CANNABIBLE, P1
[8]  
DALTON WS, 1976, CLIN PHARMACOL THER, V19, P300
[9]  
de Meijer EPM, 2003, GENETICS, V163, P335
[10]   CHARACTERIZATION OF CANNABIS ACCESSIONS WITH REGARD TO CANNABINOID CONTENT IN RELATION TO OTHER PLANT CHARACTERS [J].
DEMEIJER, EPM ;
VANDERKAMP, HJ ;
VANEEUWIJK, FA .
EUPHYTICA, 1992, 62 (03) :187-200